CA
CSLT

Cambridge Associates’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Cambridge Associates’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,636
Closed -$18K – 50
2021
Q3 		$18K Buy
+11,636
New +$22.8K ﹤0.01% 50

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cambridge Associates's CSLT Position: Q4 2021 in Review

Cambridge Associates sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q4 2021, closing a stake of 11,636 shares — an estimated $18K sold.

Cambridge Associates first reported a position in CSLT in Q3 2021 and held it in 1 quarter. The position peaked at $18K in Q3 2021. 106 funds tracked by Wall St. Rank hold CSLT as of Q4 2021.

  • Cambridge Associates reported no remaining CASTLIGHT HEALTH, INC. position as of Q4 2021 after selling out during the quarter.
  • Cambridge Associates sold 11,636 CASTLIGHT HEALTH, INC. shares in Q4 2021, an estimated $18K.
  • Cambridge Associates first reported a position in CASTLIGHT HEALTH, INC. in Q3 2021 and held it in 1 quarter.
  • Cambridge Associates's CASTLIGHT HEALTH, INC. position peaked at $18K in Q3 2021.
  • 106 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q4 2021.

Based on Cambridge Associates's 13F filing for Q4 2021, filed 11 Feb 2022.